Mouth-Held device trial offers hope for Tough-to-Treat breast cancer
NCT ID NCT07227831
Summary
This study is testing a device called TheraBionic P1 for women with advanced breast cancer that has stopped responding to standard hormone therapies and chemotherapy. Participants will use the mouth-held device daily to see if it can help control the cancer and extend survival. The main goals are to measure how long the cancer stays stable, overall survival time, and the safety of the device.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.